Below are the most recent publications written about "Multiple Myeloma" by people in Profiles.
-
Dup?r?-Richer D, Riva A, Barwick BG, Maji S, Casellas Rom?n H, Li J, De U, Sobh A, Quickstad G, Piper C, Kulis M, Ezponda T, Mart?n-Subero JI, Tonon G, Zhang W, Mitsiades CS, Boise LH, Bennett RL, Licht JD. KDM6A regulates immune response genes in multiple myeloma. Blood. 2024 10 03; 144(14):1508-1520.
-
Mignano SE, Pascal V, Odioemene NE, Forehand W, Javaugue V, Said SM, Sethi S, Sirac C, Nasr SH. Monoclonal Immunoglobulin Crystalline Membranous Nephropathy. Am J Kidney Dis. 2024 07; 84(1):120-125.
-
Hasanali ZS, Razzo B, Susanibar-Adaniya SP, Garfall AL, Stadtmauer EA, Cohen AD. Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma. Hematol Oncol Clin North Am. 2024 04; 38(2):383-406.
-
Portuguese AJ, Fang M, Tuazon SA, Pont M, Qu X, Shasha C, Comstock M, Lyons J, Cole G, Newell EW, Glynn E, Soma LA, Green DJ. Acquired CD38 gene deletion as a mechanism of tumor antigen escape in multiple myeloma. Blood Adv. 2023 12 12; 7(23):7235-7238.
-
Razzo B, Garfall AL, Cohen AD. Options at the time of relapse after anti-BCMA therapy. Hematology Am Soc Hematol Educ Program. 2023 12 08; 2023(1):450-458.
-
Cowan AJ, Pont MJ, Sather BD, Turtle CJ, Till BG, Libby EN, Coffey DG, Tuazon SA, Wood B, Gooley T, Wu VQ, Voutsinas J, Song X, Shadman M, Gauthier J, Chapuis AG, Milano F, Maloney DG, Riddell SR, Green DJ. ?-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial. Lancet Oncol. 2023 07; 24(7):811-822.
-
Richardson K, Keam SP, Zhu JJ, Meyran D, D'Souza C, Macdonald S, Campbell K, Robbins M, Bezman NA, Todd K, Quach H, Ritchie DS, Harrison SJ, Prince HM, Trapani JA, Jenkins MR, Beavis PA, Darcy PK, Neeson PJ. The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells. Haematologica. 2023 01 01; 108(1):83-97.
-
Hatch EH, Gorrell C, Abramoff BA. Contrast bath therapy for neuropathic pain due to spinal nerve root compression by myeloma: a case report. Spinal Cord Ser Cases. 2022 06 09; 8(1):59.
-
Iraqi M, Edri A, Greenshpan Y, Goldstein O, Ofir N, Bolel P, Abu Ahmad M, Zektser M, Campbell KS, Rouvio O, Gazit R, Porgador A. Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma. Int J Mol Sci. 2022 Apr 25; 23(9).
-
Caro J, Braunstein M, Williams L, Bruno B, Kaminetzky D, Siegel A, Razzo B, Alfandari S, Morgan GJ, Davies FE, Boyle EM. Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients. Leukemia. 2022 03; 36(3):613-624.